Columbia University, Herbert Irving Comprehensive Cancer Center — New York, New York

Columbia University, Herbert Irving Comprehensive Cancer Center is a clinical research site located in New York, New York, United States 10032.

Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.

Columbia University, Herbert Irving Comprehensive Cancer Center has participated in 7 clinical trials.

Therapeutic areas: Glioblastoma, Recurrent Glioblastoma, Brain Tumor.

Sponsors: Kadmon Corporation, LLC, Foghorn Therapeutics Inc., Mirati Therapeutics Inc..

Sponsor Feasibility Report

Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Columbia University, Herbert Irving Comprehensive Cancer Center?

Columbia University, Herbert Irving Comprehensive Cancer Center has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Columbia University, Herbert Irving Comprehensive Cancer Center conducted?

Columbia University, Herbert Irving Comprehensive Cancer Center has 7 clinical trials on record. Their work covers Glioblastoma, Recurrent Glioblastoma, Brain Tumor.

Is Columbia University, Herbert Irving Comprehensive Cancer Center accredited by Crixeo Health?

Yes — Columbia University, Herbert Irving Comprehensive Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Columbia University, Herbert Irving Comprehensive Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.